SILVER SPRING, Maryland | Wed Jun 20, 2012 5:17pm EDT SILVER SPRING, Maryland (Reuters) – U.S. drug advisers backed Onyx Pharmaceuticals Inc’s drug for patients who have failed to successfully treat their blood cancer with other medicines
[Continue Reading...]